ROS-mediated anticancer effects of EGFR-targeted nanoceria.
Johnson KK, Koshy P, Kopecky C, Devadason M, Biazik J, Zheng X, Jiang Y, Wang X, Liu Y, Holst J, Yang JL, Kilian KA, Sorrell CC.
Johnson KK, et al.
J Biomed Mater Res A. 2024 May;112(5):754-769. doi: 10.1002/jbm.a.37656. Epub 2023 Dec 12.
J Biomed Mater Res A. 2024.
PMID: 38084898